Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript
Molecular Partners AG(US:MOLN) Seeking Alpha·2026-02-02 21:10PresentationGood day, and welcome to the Molecular Partners call and webcast. [Operator Instructions] As a reminder, this call may be recorded. I would now like to turn the call over to Seth Lewis, Head of Investor Relations and Strategy. Please go ahead.Seth LewisSenior Vice President of Investor Relations, Communications & Strategy Thank you and welcome to today's call. My name is Seth Lewis, Head of Investor Relations and Strategy. And this morning, we're following up on the data presented this weekend a ...